Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus

Authors: Tariq Javed, Usman Ali Ashfaq, Sana Riaz, Sidra Rehman, Sheikh Riazuddin

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Hepatitis C is a major health problem causes liver cirrhosis, hepatocellular carcinoma and death. The current treatment of standard interferon in combination with ribavirin, has limited benefits due to emergence of resistant mutations during long-term treatment, adverse side effects and high cost. Hence, there is a need for the development of more effective, less toxic antiviral agents.

Results

The present study was designed to search anti-HCV plants from different areas of Pakistan. Ten medicinal plants were collected and tested for anti-HCV activity by infecting the liver cells with HCV 3a innoculum. Methanol and chloroform extracts of Solanum nigrum (SN) seeds exhibited 37% and more than 50% inhibition of HCV respectively at non toxic concentration. Moreover, antiviral effect of SN seeds extract was also analyzed against HCV NS3 protease by transfecting HCV NS3 protease plasmid into liver cells. The results demonstrated that chloroform extract of SN decreased the expression or function of HCV NS3 protease in a dose- dependent manner and GAPDH remained constant.

Conclusion

These results suggest that SN extract contains potential antiviral agents against HCV and combination of SN extract with interferon will be better option to treat chronic HCV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Giannini C, Brechot C: Hepatitis C virus biology. Cell Death Differ 2003,10(Suppl 1):S27-38. 10.1038/sj.cdd.4401121CrossRefPubMed Giannini C, Brechot C: Hepatitis C virus biology. Cell Death Differ 2003,10(Suppl 1):S27-38. 10.1038/sj.cdd.4401121CrossRefPubMed
2.
3.
go back to reference Parker SP, Khan HI, Cubitt WD: Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. J Clin Microbiol 1999, 37: 2061-2063.PubMedCentralPubMed Parker SP, Khan HI, Cubitt WD: Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. J Clin Microbiol 1999, 37: 2061-2063.PubMedCentralPubMed
4.
go back to reference Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8: 69. 10.1186/1471-2334-8-69PubMedCentralCrossRefPubMed Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8: 69. 10.1186/1471-2334-8-69PubMedCentralCrossRefPubMed
5.
go back to reference De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G: Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res 2003, 58: 1-16. 10.1016/S0166-3542(03)00028-7CrossRefPubMed De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G: Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res 2003, 58: 1-16. 10.1016/S0166-3542(03)00028-7CrossRefPubMed
6.
go back to reference Reed KE, Rice CM: Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000, 242: 55-84.PubMed Reed KE, Rice CM: Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000, 242: 55-84.PubMed
7.
go back to reference Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 1993, 67: 3835-3844.PubMedCentralPubMed Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 1993, 67: 3835-3844.PubMedCentralPubMed
9.
go back to reference Beaulieu PL, Tsantrizos YS: Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Curr Opin Investig Drugs 2004, 5: 838-850.PubMed Beaulieu PL, Tsantrizos YS: Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Curr Opin Investig Drugs 2004, 5: 838-850.PubMed
10.
go back to reference Bacon BR, Shiffman ML, Mendes F, Ghalib R, Hassanein T, Morelli G, Joshi S, Rothstein K, Kwo P, Gitlin N: Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results. Hepatology 2009, 49: 1838-1846. 10.1002/hep.22871CrossRefPubMed Bacon BR, Shiffman ML, Mendes F, Ghalib R, Hassanein T, Morelli G, Joshi S, Rothstein K, Kwo P, Gitlin N: Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results. Hepatology 2009, 49: 1838-1846. 10.1002/hep.22871CrossRefPubMed
11.
go back to reference Moradpour D, Blum HE: Current and evolving therapies for hepatitis C. Eur J Gastroenterol Hepatol 1999, 11: 1199-1202. 10.1097/00042737-199911000-00002CrossRefPubMed Moradpour D, Blum HE: Current and evolving therapies for hepatitis C. Eur J Gastroenterol Hepatol 1999, 11: 1199-1202. 10.1097/00042737-199911000-00002CrossRefPubMed
12.
go back to reference Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358: 958-965. 10.1016/S0140-6736(01)06102-5CrossRefPubMed Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358: 958-965. 10.1016/S0140-6736(01)06102-5CrossRefPubMed
13.
go back to reference Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347: 975-982. 10.1056/NEJMoa020047CrossRefPubMed Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347: 975-982. 10.1056/NEJMoa020047CrossRefPubMed
14.
go back to reference Schiff ER: Emerging strategies for pegylated interferon combination therapy. Nat Clin Pract Gastroenterol Hepatol 2007,4(Suppl 1):S17-21. 10.1038/ncpgasthep0691CrossRefPubMed Schiff ER: Emerging strategies for pegylated interferon combination therapy. Nat Clin Pract Gastroenterol Hepatol 2007,4(Suppl 1):S17-21. 10.1038/ncpgasthep0691CrossRefPubMed
15.
go back to reference Kinghorn AD: The discovery of drugs from higher plants. Biotechnology 1994, 26: 81-108.PubMed Kinghorn AD: The discovery of drugs from higher plants. Biotechnology 1994, 26: 81-108.PubMed
16.
go back to reference Slichenmyer WJ, Von Hoff DD: Taxol: a new and effective anti-cancer drug. Anticancer Drugs 1991, 2: 519-530. 10.1097/00001813-199112000-00002CrossRefPubMed Slichenmyer WJ, Von Hoff DD: Taxol: a new and effective anti-cancer drug. Anticancer Drugs 1991, 2: 519-530. 10.1097/00001813-199112000-00002CrossRefPubMed
17.
go back to reference Jassim SA, Naji MA: Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 2003, 95: 412-427. 10.1046/j.1365-2672.2003.02026.xCrossRefPubMed Jassim SA, Naji MA: Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 2003, 95: 412-427. 10.1046/j.1365-2672.2003.02026.xCrossRefPubMed
18.
19.
go back to reference el-Awady MK, Tabll AA, el-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, Bader el-Din NG, Redwan el RM, el-Demellawy M, Omran MH, et al.: HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol 2006, 12: 4836-4842.PubMedCentralPubMed el-Awady MK, Tabll AA, el-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, Bader el-Din NG, Redwan el RM, el-Demellawy M, Omran MH, et al.: HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol 2006, 12: 4836-4842.PubMedCentralPubMed
20.
go back to reference Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4CrossRefPubMed Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4CrossRefPubMed
21.
go back to reference Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, Sureau C, Fabre JM, Sacunha A, Larrey D, et al.: Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 2008, 82: 569-574. 10.1128/JVI.01443-07PubMedCentralCrossRefPubMed Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, Sureau C, Fabre JM, Sacunha A, Larrey D, et al.: Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 2008, 82: 569-574. 10.1128/JVI.01443-07PubMedCentralCrossRefPubMed
22.
go back to reference McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998, 339: 1485-1492. 10.1056/NEJM199811193392101CrossRefPubMed McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998, 339: 1485-1492. 10.1056/NEJM199811193392101CrossRefPubMed
23.
go back to reference Moore MM, Elpern DJ, Carter DJ: Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004, 140: 215-217. 10.1001/archderm.140.2.215PubMed Moore MM, Elpern DJ, Carter DJ: Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004, 140: 215-217. 10.1001/archderm.140.2.215PubMed
24.
go back to reference Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H: The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997, 79: 1494-1500. 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-BCrossRefPubMed Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H: The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997, 79: 1494-1500. 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-BCrossRefPubMed
25.
go back to reference Hattori T, Ikematsu S, Koito A, Matsushita S, Maeda Y, Hada M, Fujimaki M, Takatsuki K: Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res 1989, 11: 255-261. 10.1016/0166-3542(89)90035-1CrossRefPubMed Hattori T, Ikematsu S, Koito A, Matsushita S, Maeda Y, Hada M, Fujimaki M, Takatsuki K: Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res 1989, 11: 255-261. 10.1016/0166-3542(89)90035-1CrossRefPubMed
26.
go back to reference Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY: Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology 2007, 132: 1925-1936. 10.1053/j.gastro.2007.02.038CrossRefPubMed Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY: Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology 2007, 132: 1925-1936. 10.1053/j.gastro.2007.02.038CrossRefPubMed
27.
go back to reference Chopra RN, Nayar SL, Chopra IC: Glossarys of Indian medicinal plants. CSIR: New Delhi; 1956:229. Chopra RN, Nayar SL, Chopra IC: Glossarys of Indian medicinal plants. CSIR: New Delhi; 1956:229.
28.
go back to reference Perez RM, Perez JA, Garcia LM, Sossa H: Neuropharmacological activity of Solanum nigrum fruit. J Ethnopharmacol 1998, 62: 43-48. 10.1016/S0378-8741(98)00059-2CrossRefPubMed Perez RM, Perez JA, Garcia LM, Sossa H: Neuropharmacological activity of Solanum nigrum fruit. J Ethnopharmacol 1998, 62: 43-48. 10.1016/S0378-8741(98)00059-2CrossRefPubMed
29.
go back to reference Jainu M, Devi CS: Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation. J Ethnopharmacol 2006, 104: 156-163. 10.1016/j.jep.2005.08.064CrossRefPubMed Jainu M, Devi CS: Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation. J Ethnopharmacol 2006, 104: 156-163. 10.1016/j.jep.2005.08.064CrossRefPubMed
30.
go back to reference Lin HM, Tseng HC, Wang CJ, Lin JJ, Lo CW, Chou FP: Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chem Biol Interact 2008, 171: 283-293. 10.1016/j.cbi.2007.08.008CrossRefPubMed Lin HM, Tseng HC, Wang CJ, Lin JJ, Lo CW, Chou FP: Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chem Biol Interact 2008, 171: 283-293. 10.1016/j.cbi.2007.08.008CrossRefPubMed
31.
go back to reference Wannang NN, Anuka JA, Kwanashie HO, Gyang SS, Auta A: Anti-seizure activity of the aqueous leaf extract of Solanum nigrum linn (solanaceae) in experimental animals. Afr Health Sci 2008, 8: 74-79.PubMedCentralPubMed Wannang NN, Anuka JA, Kwanashie HO, Gyang SS, Auta A: Anti-seizure activity of the aqueous leaf extract of Solanum nigrum linn (solanaceae) in experimental animals. Afr Health Sci 2008, 8: 74-79.PubMedCentralPubMed
32.
go back to reference Harborne JB, Phytochemical methods: A guid to 70 modern methods of plants analysis. Chapman and Onyenuga, V.A. and B.L. Fetuga, First Nationalhall, New York; 1995:7-43. Harborne JB, Phytochemical methods: A guid to 70 modern methods of plants analysis. Chapman and Onyenuga, V.A. and B.L. Fetuga, First Nationalhall, New York; 1995:7-43.
33.
go back to reference Ayafor JF, Tchuendem MH, Nyasse B, Tillequin F, Anke H: Novel bioactive diterpenoids from Aframomum aulacocarpos. J Nat Prod 1994, 57: 917-923. 10.1021/np50109a007CrossRefPubMed Ayafor JF, Tchuendem MH, Nyasse B, Tillequin F, Anke H: Novel bioactive diterpenoids from Aframomum aulacocarpos. J Nat Prod 1994, 57: 917-923. 10.1021/np50109a007CrossRefPubMed
34.
go back to reference Perrett S, Whitfield PJ, Sanderson L, Bartlett A: The plant molluscicide Millettia thonningii (Leguminosae) as a topical antischistosomal agent. J Ethnopharmacol 1995, 47: 49-54. 10.1016/0378-8741(95)01253-ACrossRefPubMed Perrett S, Whitfield PJ, Sanderson L, Bartlett A: The plant molluscicide Millettia thonningii (Leguminosae) as a topical antischistosomal agent. J Ethnopharmacol 1995, 47: 49-54. 10.1016/0378-8741(95)01253-ACrossRefPubMed
35.
go back to reference Afolayan AJ, Meyer JJ: The antimicrobial activity of 3,5,7-trihydroxyflavone isolated from the shoots of Helichrysum aureonitens. J Ethnopharmacol 1997, 57: 177-181. 10.1016/S0378-8741(97)00065-2CrossRefPubMed Afolayan AJ, Meyer JJ: The antimicrobial activity of 3,5,7-trihydroxyflavone isolated from the shoots of Helichrysum aureonitens. J Ethnopharmacol 1997, 57: 177-181. 10.1016/S0378-8741(97)00065-2CrossRefPubMed
36.
go back to reference Pause A, Kukolj G, Bailey M, Brault M, Do F, Halmos T, Lagace L, Maurice R, Marquis M, McKercher G, et al.: An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J Biol Chem 2003, 278: 20374-20380. 10.1074/jbc.M210785200CrossRefPubMed Pause A, Kukolj G, Bailey M, Brault M, Do F, Halmos T, Lagace L, Maurice R, Marquis M, McKercher G, et al.: An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J Biol Chem 2003, 278: 20374-20380. 10.1074/jbc.M210785200CrossRefPubMed
37.
go back to reference Borowski P, Heiland M, Oehlmann K, Becker B, Kornetzky L, Feucht H, Laufs R: Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. Eur J Biochem 1996, 237: 611-618. 10.1111/j.1432-1033.1996.0611p.xCrossRefPubMed Borowski P, Heiland M, Oehlmann K, Becker B, Kornetzky L, Feucht H, Laufs R: Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. Eur J Biochem 1996, 237: 611-618. 10.1111/j.1432-1033.1996.0611p.xCrossRefPubMed
38.
go back to reference Sakamuro D, Furukawa T, Takegami T: Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995, 69: 3893-3896.PubMedCentralPubMed Sakamuro D, Furukawa T, Takegami T: Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995, 69: 3893-3896.PubMedCentralPubMed
39.
go back to reference Zuo G, Li Z, Chen L, Xu X: Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease. Antiviral Res 2007, 76: 86-92. 10.1016/j.antiviral.2007.06.001CrossRefPubMed Zuo G, Li Z, Chen L, Xu X: Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease. Antiviral Res 2007, 76: 86-92. 10.1016/j.antiviral.2007.06.001CrossRefPubMed
Metadata
Title
In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
Authors
Tariq Javed
Usman Ali Ashfaq
Sana Riaz
Sidra Rehman
Sheikh Riazuddin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-26

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.